BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6381556)

  • 1. A placebo-controlled, double-blind trial of amitriptyline in bulimia.
    Mitchell JE; Groat R
    J Clin Psychopharmacol; 1984 Aug; 4(4):186-93. PubMed ID: 6381556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study.
    Biederman J; Herzog DB; Rivinus TM; Harper GP; Ferber RA; Rosenbaum JF; Harmatz JS; Tondorf R; Orsulak PJ; Schildkraut JJ
    J Clin Psychopharmacol; 1985 Feb; 5(1):10-6. PubMed ID: 3973067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant drug therapy for bulimia: current status.
    Pope HG; Hudson JI
    J Clin Psychiatry; 1986 Jul; 47(7):339-45. PubMed ID: 3087968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of bulimia with fenfluramine and desipramine.
    Blouin AG; Blouin JH; Perez EL; Bushnik T; Zuro C; Mulder E
    J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of anorexia nervosa and bulimia.
    Herzog DB
    Pediatr Ann; 1984 Dec; 13(12):915, 918-9, 923. PubMed ID: 6395077
    [No Abstract]   [Full Text] [Related]  

  • 8. A placebo-controlled study of trazodone in bulimia nervosa.
    Pope HG; Keck PE; McElroy SL; Hudson JI
    J Clin Psychopharmacol; 1989 Aug; 9(4):254-9. PubMed ID: 2671058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.
    Arch Gen Psychiatry; 1992 Feb; 49(2):139-47. PubMed ID: 1550466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine.
    Kennedy SH; Goldbloom DS; Ralevski E; Davis C; D'Souza JD; Lofchy J
    J Clin Psychopharmacol; 1993 Dec; 13(6):415-22. PubMed ID: 8120155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of the efficacy and safety of dothiepin hydrochloride in the treatment of major depressive disorder.
    Stratas NE
    J Clin Psychiatry; 1984 Nov; 45(11):466-9. PubMed ID: 6386793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice.
    Hollyman JA; Freeling P; Paykel ES; Bhat A; Sedgwick P
    J R Coll Gen Pract; 1988 Sep; 38(314):393-7. PubMed ID: 3076905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of isocarboxazid in the treatment of bulimia nervosa.
    Kennedy SH; Piran N; Warsh JJ; Prendergast P; Mainprize E; Whynot C; Garfinkel PE
    J Clin Psychopharmacol; 1988 Dec; 8(6):391-6. PubMed ID: 3069879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulimia treated with imipramine: a placebo-controlled, double-blind study.
    Pope HG; Hudson JI; Jonas JM; Yurgelun-Todd D
    Am J Psychiatry; 1983 May; 140(5):554-8. PubMed ID: 6342421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy.
    Fichter MM; Leibl K; Rief W; Brunner E; Schmidt-Auberger S; Engel RR
    Pharmacopsychiatry; 1991 Jan; 24(1):1-7. PubMed ID: 2011615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.